106 related articles for article (PubMed ID: 18072206)
21. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein.
GrandPré T; Nakamura F; Vartanian T; Strittmatter SM
Nature; 2000 Jan; 403(6768):439-44. PubMed ID: 10667797
[TBL] [Abstract][Full Text] [Related]
22. Human Nogo-C overexpression induces HEK293 cell apoptosis via a mechanism that involves JNK-c-Jun pathway.
Chen Y; Tang X; Cao X; Chen H; Zhang X
Biochem Biophys Res Commun; 2006 Sep; 348(3):923-8. PubMed ID: 16905119
[TBL] [Abstract][Full Text] [Related]
23. The N- and C-termini of the human Nogo molecules are intrinsically unstructured: bioinformatics, CD, NMR characterization, and functional implications.
Li M; Song J
Proteins; 2007 Jul; 68(1):100-8. PubMed ID: 17397058
[TBL] [Abstract][Full Text] [Related]
24. Meiotic inactivation of Xenopus Myt1 by CDK/XRINGO, but not CDK/cyclin, via site-specific phosphorylation.
Ruiz EJ; Hunt T; Nebreda AR
Mol Cell; 2008 Oct; 32(2):210-20. PubMed ID: 18951089
[TBL] [Abstract][Full Text] [Related]
25. Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.
Kim SG; Kim SN; Jong HS; Kim NK; Hong SH; Kim SJ; Bang YJ
Oncogene; 2001 Mar; 20(10):1254-65. PubMed ID: 11313870
[TBL] [Abstract][Full Text] [Related]
26. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp.
Wang KC; Kim JA; Sivasankaran R; Segal R; He Z
Nature; 2002 Nov; 420(6911):74-8. PubMed ID: 12422217
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation at Tyr-694 of Nogo-A by Src-family kinases.
Yokoyama K; Tezuka T; Hoshina N; Nakazawa T; Yamamoto T
Biochem Biophys Res Commun; 2006 Nov; 349(4):1401-5. PubMed ID: 16979591
[TBL] [Abstract][Full Text] [Related]
28. Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.
Nabha SM; Mohammad RM; Dandashi MH; Coupaye-Gerard B; Aboukameel A; Pettit GR; Al-Katib AM
Clin Cancer Res; 2002 Aug; 8(8):2735-41. PubMed ID: 12171907
[TBL] [Abstract][Full Text] [Related]
29. Identification of two NOGO/RTN4 genes and analysis of Nogo-A expression in Xenopus laevis.
Klinger M; Diekmann H; Heinz D; Hirsch C; Hannbeck von Hanwehr S; Petrausch B; Oertle T; Schwab ME; Stuermer CA
Mol Cell Neurosci; 2004 Feb; 25(2):205-16. PubMed ID: 15019938
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of Noga-A in ALS muscle biopsies is not unique for this disease.
Wojcik S; Engel WK; Askanas V
Acta Myol; 2006 Dec; 25(3):116-8. PubMed ID: 17626519
[TBL] [Abstract][Full Text] [Related]
31. Nogo-A at CNS paranodes is a ligand of Caspr: possible regulation of K(+) channel localization.
Nie DY; Zhou ZH; Ang BT; Teng FY; Xu G; Xiang T; Wang CY; Zeng L; Takeda Y; Xu TL; Ng YK; Faivre-Sarrailh C; Popko B; Ling EA; Schachner M; Watanabe K; Pallen CJ; Tang BL; Xiao ZC
EMBO J; 2003 Nov; 22(21):5666-78. PubMed ID: 14592966
[TBL] [Abstract][Full Text] [Related]
32. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
[TBL] [Abstract][Full Text] [Related]
33. A maternal form of the phosphatase Cdc25A regulates early embryonic cell cycles in Xenopus laevis.
Kim SH; Li C; Maller JL
Dev Biol; 1999 Aug; 212(2):381-91. PubMed ID: 10433828
[TBL] [Abstract][Full Text] [Related]
34. A new role for Nogo as a regulator of vascular remodeling.
Acevedo L; Yu J; Erdjument-Bromage H; Miao RQ; Kim JE; Fulton D; Tempst P; Strittmatter SM; Sessa WC
Nat Med; 2004 Apr; 10(4):382-8. PubMed ID: 15034570
[TBL] [Abstract][Full Text] [Related]
35. Nogo-A, -B, and -C are found on the cell surface and interact together in many different cell types.
Dodd DA; Niederoest B; Bloechlinger S; Dupuis L; Loeffler JP; Schwab ME
J Biol Chem; 2005 Apr; 280(13):12494-502. PubMed ID: 15640160
[TBL] [Abstract][Full Text] [Related]
36. Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1.
Chen S; Xu Y; Yuan X; Bubley GJ; Balk SP
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15969-74. PubMed ID: 17043241
[TBL] [Abstract][Full Text] [Related]
37. Biochemical differences between staurosporine-induced apoptosis and premature mitosis.
Yoshida M; Usui T; Tsujimura K; Inagaki M; Beppu T; Horinouchi S
Exp Cell Res; 1997 May; 232(2):225-39. PubMed ID: 9168797
[TBL] [Abstract][Full Text] [Related]
38. Glutamate provides a key structural contact between reticulon-4 (Nogo-66) and phosphocholine.
Alhoshani A; Vithayathil R; Bandong J; Chrunyk KM; Moreno GO; Weiss GA; Cocco MJ
Biochim Biophys Acta; 2014 Sep; 1838(9):2350-6. PubMed ID: 24863057
[TBL] [Abstract][Full Text] [Related]
39. AZ703, an imidazo[1,2-a]pyridine inhibitor of cyclin-dependent kinases 1 and 2, induces E2F-1-dependent apoptosis enhanced by depletion of cyclin-dependent kinase 9.
Cai D; Byth KF; Shapiro GI
Cancer Res; 2006 Jan; 66(1):435-44. PubMed ID: 16397259
[TBL] [Abstract][Full Text] [Related]
40. Pro-apoptotic ASY/Nogo-B protein associates with ASYIP.
Qi B; Qi Y; Watari A; Yoshioka N; Inoue H; Minemoto Y; Yamashita K; Sasagawa T; Yutsudo M
J Cell Physiol; 2003 Aug; 196(2):312-8. PubMed ID: 12811824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
